Lv1
38 积分 2025-01-09 加入
Targeting Metabolic and pH Regulatory Pathways in Cancer via Dual Inhibition of Nicotinamide Phosphoribosyltransferase and Carbonic Anhydrases IX and XII
4天前
已完结
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
29天前
已完结
Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons
1个月前
已完结
PARP7 as a new target for activating anti-tumor immunity in cancer
1个月前
已完结
Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD+ Salvage Synthesis
1个月前
已完结
TMET-19. Targeting NQO1 and the NAD+ Salvage Pathway: A Novel Therapeutic Strategy for Glioblastoma
1个月前
已关闭
Discovery of Potent PDEδ/NAMPT Dual Inhibitors: Preclinical Evaluation in KRAS Mutant Pancreatic Cancer Cells
1个月前
已完结
Dual-Target Inhibitors Based on COX-2: A Review from Medicinal Chemistry Perspectives
1个月前
已完结
Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
1个月前
已完结
Dual PARP/NAMPT Inhibitors for BRCA Wild-Type Triple-Negative Breast Cancer: Disrupting Homologous Recombination Repair and Activating Antitumor Immunity
1个月前
已完结
皖公网安备34019202002308
